NobleCon 18. GABY CEO Margot Micallef presented at NobleCon18. The Company highlighted the transformation of the Company in 2021, growth opportunities and potential for expansion in the future. A rebroadcast is available at https://noble.mediasite.com/mediasite/Catalog/Full/4ec6170801b441318e66ea53d53540a421.Mankind-Flagship Retail Dispensary. The Mankind dispensary is generating over $2 million in monthly revenue, with approximately 40% of monthly sales coming from curbside pickup and delivery. Mankind serves its 700 distinct cannabis products to over 27,000 monthly customers.California Remains the Focus. California is the world’s leading and largest cannabis market, with a deep cannabis culture, with the legal market projected to top $7 billion by 2024. The California market remains highly fragmented with numerous growth opportunities, including additional localities enabling dispensaries, as well as moving to a legal market from illicit.Proprietary Brands. GABY's Kind Republic brand accounts for roughly 20% of flower sales. KR sold nearly $2 million of product at Mankind in the past 12 months at a 75% gross margin. The product line is being expanded into vapes, concentrates, and pre-rolls, which will drive additional high gross margin business, in our view. The Company has taken initial steps to sell Kind Republic through other dispensaries.Maintaining Our Outperform Rating. We are maintaining our outperform rating on GABY, Inc. with a $0.05 12-month price target. GABY is a consolidator of retail dispensaries focused exclusively on California. The Company made its first major acquisition on February 15, 2021 with the purchase of Miramar Professional Services, parent company of Mankind Dispensary, one of the highest grossing dispensaries in California. GABY boasts a management team with extensive experience in retail consolidation, operations, data analytics, and cannabis. We expect management to use the Mankind acquisition as a template for additional growth going forward. Read More >>